A carregar...
Expression of phosphorylated Hippo pathway kinases (MST1/2 and LATS1/2) in HER2-positive and triple-negative breast cancer patients treated with neoadjuvant therapy
The Hippo kinases MST1/2 and LATS1/2 inhibit the oncoproteins TAZ/YAP and regulate T cell function. Hippo kinases also cooperate with the ATR-Chk1 and ATM-Chk2 pathways, central orchestrators of the DNA damage response (DDR). We hypothesized that MST1/2 and LATS1/2 localization differently impacts t...
Na minha lista:
Publicado no: | Cancer Biol Ther |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Taylor & Francis
2017
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5499753/ https://ncbi.nlm.nih.gov/pubmed/28387539 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2017.1312230 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|